“The American Medical Association applauds Illinois Governor Rod Blagojevich for signing into law a new state-wide smoking ban ? the strongest clean indoor air law in the country”, stated by Ronald M. Davis, MD, President, American Medical Association.
This is an analysis of existing data that has been previously published (online in Diabetes Care, 29 May 2007) and provides no new information on the risk of heart failure associated with the thiazolinediones (TZD) class.
Warning that children have special susceptibility to harmful chemical exposure with life-long effects, the United Nations health agency has said that more than 30 per cent of the global burden of disease in children is attributable to environment factors.
The U.S. Food and Drug Administration announced that it is permitting the restricted use of Zelnorm (tegaserod maleate) under a treatment investigational new drug (IND) protocol to treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC) in women younger than 55 who meet specific guidelines.
A class of drugs commonly used to treat type 2 diabetes may double the risk of heart failure, according to a new analysis by researchers at Wake Forest University School of Medicine and colleagues.
Health Canada is advising consumers not to use Liviro3, a natural health product marketed for sexual enhancement, due to concerns about possible side-effects. The product is not authorized for sale in Canada and has not been found in the Canadian marketplace, but is for sale on the Internet, and may have been brought into the country by travellers.
Use of the pulmonary artery catheter decreased by 65 percent in the US between 1993 and 2004, possibly due to growing evidence that this invasive procedure does not reduce the risk of death for hospitalized patients, according to a study in the July 25 issue of JAMA.
Got high cholesterol? You might want to stay away from air pollution. That?s the message of a new UCLA study linking diesel exhaust to atherosclerosis, or hardening of the arteries, which significantly increases one?s risk for heart attack and stroke.
High-risk patients with hypertrophic cardiomyopathy appear to have reduced risk of sudden cardiac death with an implantable cardioverter-defibrillator that terminates dangerous heart rhythm disorders, according to a study in the July 25 issue of JAMA.
A type 2 diabetes drug taken orally and in widespread use for more than a decade has been found to have distinct advantages over nine other, mostly newer medications used to control the chronic disease, according to a study by researchers at Johns Hopkins.